The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

The first peer-reviewed journal in the field of human gene therapy, providing all-inclusive coverage of the research, methods, and clinical developments that are driving today's explosion of gene ...

In 1976, a small company called Genentech opened in the San Francisco Bay Area. Considered the first genetic engineering company, Genentech, one of the creators of recombinant DNA technology, has ...